The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell lung cancer (NSCLC), yielded durable responses with a highly manageable ...

Baylor Medicine’s Interstitial Lung Disease (ILD) program offers specialized and multidisciplinary care. We bring together a unique team of physicians of multiple sub-specialties for patients with a ...

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid arthritis and RA-associated interstitial lung disease, according to findings ...

A collection of immune cells known as a granuloma that results from chronic inflammation in the interstitial lung disease sarcoidosis. White dots indicate the receptor NRP2, which is overexpressed ...

The method was first applied under compassionate use in a 2-year-old patient with end-stage interstitial lung disease and no possibility of lung transplantation. Despite multiple immunosuppressive ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...